Clinical Trials in Chicago

Showing 5221-5240 of 20,493 trials

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

NCT03279185

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.

HIV/AIDS

Harvard School of Public Health (HSPH)334 participantsStarted Nov 2017

Los Angeles, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +6 more locations

Active Not RecruitingPhase 12.2 miles

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

NCT04603001

This is an open-label, multi-center Phase 1 study of LY3410738, an oral, covalent isocitrate dehydrogenase (IDH) inhibitor, in patients with IDH1 and/or IDH2-mutant advanced hematologic malignancies who may have received standard therapy

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more

Eli Lilly and Company260 participantsStarted Nov 2020

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +34 more locations

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Find Trials by Condition in Chicago

Gluten Technology and Education for Celiac Health

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Study of V117957 in Overactive Bladder Syndrome

Post-Approval Study of the TREO Abdominal Stent-Graft System

Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

LTFU for All Cell and Gene Therapy Studies

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

Effect of Ketamine and Etomidate During RSI on Long Term Outcomes

Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Cough Reduction in IPF With Nalbuphine ER

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients